eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Contemporary Oncology
1/2018
 
the latest issue:
 

 
Review paper

Personalized medicine in oncology. New perspectives in management of gliomas

Justyna Gil, Izabela Laczmanska, Karolina A. Pesz, Maria M. Sasiadek
Contemp Oncol (Pozn) 2018; 22 (1A): 1–2
 
DOI: https://doi.org/10.5114/wo.2018.73872
Review paper

Immune consequences of anti-angiogenic therapy in renal cell carcinoma

Klaudia K. Brodaczewska, Cezary Szczylik, Claudine Kieda
Contemp Oncol (Pozn) 2018; 22 (1A): 14–22
 
DOI: https://doi.org/10.5114/wo.2018.73878
Review paper

Heme oxygenase inhibition in cancers: possible tools and targets

Paulina Podkalicka, Olga Mucha, Alicja Józkowicz, Józef Dulak, Agnieszka Łoboda
Contemp Oncol (Pozn) 2018; 22 (1A): 23–32
 
DOI: https://doi.org/10.5114/wo.2018.73879
Original paper

Gastric cancer increases transmigratory potential of peripheral blood monocytes by upregulation of β1- and β2-integrins

Andrzej Eljaszewicz, Michal Jankowski, Malgorzata Wiese-Szadkowska, Lidia Gackowska, Jacek Michalkiewicz, Wojciech Zegarski, Marcin Moniuszko
Contemp Oncol (Pozn) 2018; 22 (1A): 33–37
 
DOI: https://doi.org/10.5114/wo.2018.73881
Original paper

Challenging tumour immunological techniques that help to track cancer stem cells in malignant melanomas and other solid tumours

Beatrix Kotlan, Vanda Plotar, Klara Eles, Szabolcs Horvath, Timea Balatoni, Orsolya Csuka, Mihaly Újhelyi, Ákos Sávolt, Andras Szollar, Istvan Vamosi-Nagy, Laszlo Toth, Emil Farkas, Jozsef Toth, Miklos Kasler, Gabriella Liszkay
Contemp Oncol (Pozn) 2018; 22 (1A): 41–47
 
DOI: https://doi.org/10.5114/wo.2018.73884
Review paper

Surface markers of cancer stem-like cells of ovarian cancer and their clinical relevance

Aleksandra Klemba, J. Karolina Purzycka-Olewiecka, Gabriel Wcisło, Anna M. Czarnecka, Sławomir Lewicki, Bogdan Lesyng, Cezary Szczylik, Claudine Kieda
Contemp Oncol (Pozn) 2018; 22 (1A): 48–55
 
DOI: https://doi.org/10.5114/wo.2018.73885
Review paper

The revival of CpG oligonucleotide-based cancer immunotherapies

Tomasz Adamus, Marcin Kortylewski
Contemp Oncol (Pozn) 2017; 21 (1A): 56–60
 
DOI: https://doi.org/10.5114/wo.2018.73887
Original paper

Immunotherapy of melanoma

Iwona Lugowska, Pawel Teterycz, Piotr Rutkowski
Contemp Oncol (Pozn) 2018; 22 (1A): 61–67
 
DOI: https://doi.org/10.5114/wo.2018.73889
Review paper

BRAF and MEK inhibitors in the era of immunotherapy in melanoma patients

Jacek Mackiewicz, Andrzej Mackiewicz
Contemp Oncol (Pozn) 2018; 22 (1A): 68–72
 
DOI: https://doi.org/10.5114/wo.2018.73890
Review paper

Versatile CAR T-cells for cancer immunotherapy

Fuliang Chu, Jingjing Cao, Sattva S. Neelalpu
Contemp Oncol (Pozn) 2018; 22 (1A): 73–80
 
DOI: https://doi.org/10.5114/wo.2018.73892
Review paper

Clinical and immunological correlates of long term survival in glioblastoma

Bartosz Czapski, Szymon Baluszek, Christel Herold-Mende, Bozena Kaminska
Contemp Oncol (Pozn) 2018; 22 (1A): 81–85
 
DOI: https://doi.org/10.5114/wo.2018.73893
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe